Myriad Genetics, Inc. MYGN recently made SneakPeek available over the counter in more than 8,800 retail locations nationwide.

Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, continues to empower parents with increased access to prenatal testing. SneakPeek, the #1 OBGYN-recommended ...

If you or your partner is currently pregnant, you’ll be thrilled you know there’s a new baby gender predictor on the market ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The familial trend, it turned out, was linked to a genetic mutation. That meant Bill might also be at risk for the disease.

Concerns about 23andMe's business prospects is raising questions about the genetic testing company's customer data.

Researchers at University of California San Francisco (UCSF) have developed a single genomic test that can quickly detect ...

A genomic test developed at UC San Francisco to rapidly detect almost any kind of pathogen—virus, bacteria, fungus or ...

Montgomery said the DNA from Sara and Madison was tested against more than 15 people’s DNA profiles, including Locke, his ...

DNA testing of 14 individuals buried in the ancient Roman city of Pompeii has shown their sex and ethnic background is different to what earlier archaeologists assumed. Nuclear and mitochondrial ...

A genomic test developed by researchers to rapidly detect almost any kind of pathogen -- virus, bacteria, fungus or parasite -- has proved successful after a decade of use.